About
Ipsen Sa (PINK:IPSEF) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Ipsen S.A. - Information relating to the holding of the Combined Shareholders’ Meeting of 13 May 2026
Apr 22 2026
Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration
Apr 3 2026
Ipsen announces that Beech Tree has obtained an exemption from the obligation to submit a public tender offer
Apr 1 2026
Ipsen announces the availability of its 2025 Universal Registration Document
Mar 18 2026
Ipsen showcases transformative potential of early immuno-oncology pipeline at AACR
Financials
Revenue
$3.93 B
Market Cap
$9.32 B
P/E Ratio
18.07
EPS
6.26
Dividend Yield
1.24%
Translate